Keyphrases
5-fluorouracil (5-FU)
23%
Cancer Care
17%
Cancer Care Coordination
18%
Cancer Patients
24%
Care Coordination
37%
Catenin
26%
Chediak-Higashi Syndrome
35%
Chemotherapy
21%
Clinical Research
15%
Clinical Trials
23%
Colon
17%
Colon Adenocarcinoma
13%
Colon Cancer
41%
Colonic mucosa
11%
Gemcitabine
18%
Genistein
12%
Hawaii
18%
Health Systems
19%
Healthcare Professionals
17%
In Cancer
24%
Inflammatory Bowel Disease
15%
Interferon-α (IFN-α)
12%
Interleukin-2
12%
LAMP2
22%
LEF1
17%
Levamisole
34%
Lipids
12%
Metastatic Colorectal Cancer (mCRC)
22%
New York City
15%
Oncohematology
16%
Oncologists
13%
Patient Perception
12%
Patient Satisfaction
19%
Peripheral Blood Mononuclear Cells
25%
Resveratrol
17%
Rural Patients
13%
Signaling Pathway
17%
Southwest Oncology Group
15%
Surface Expression
12%
T Cell Receptor
14%
T Cells
18%
Tumor
17%
Tumor Microenvironment
16%
United States
13%
Wnt Antagonists
17%
Wnt Genes
12%
Wnt Ligands
23%
Wnt Signaling
47%
Wnt Signaling Pathway
44%
Wnt2
12%
Medicine and Dentistry
Breast Cancer
18%
Cancer
25%
Cancer Prevention
9%
Cancer Therapy
20%
Carcinogenesis
15%
Care Coordination
37%
Catenin
8%
Cell Invasion
10%
Chediak Higashi Syndrome
9%
Cholangiocarcinoma
15%
Clinical Research
20%
Clinical Trial
29%
Clinician
8%
Colon Carcinoma
30%
Colon Mucosa
8%
Diseases
20%
Frizzled Protein
12%
Gastroesophageal Junction
7%
Gemcitabine
13%
Granulocyte
12%
Health Care Cost
11%
Health Care Personnel
10%
Hematology
21%
In Vitro
11%
Inflammatory Bowel Disease
10%
Interleukin 2
7%
Levamisole
15%
Low Drug Dose
9%
Lymphocyte
8%
Lymphoid Enhancer Factor 1
10%
Malignant Neoplasm
100%
Mammography
10%
Melanoma
7%
Mesenchymal-Epithelial Transition
7%
Metastatic Carcinoma
10%
Neoplasm
8%
Oncologist
12%
Oncology
54%
Overall Survival
9%
Pancreas Cancer
10%
Patient Satisfaction
10%
Peripheral Blood Mononuclear Cell
8%
Platelet
7%
Prescription Medication
7%
Radiation Therapy
9%
Receptor
8%
Resveratrol
7%
Tumor
11%
Tumor Microenvironment
11%
Wnt Signaling
43%